# A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)

Study · id `cardio:ct-nct01075282` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01075282](<https://clinicaltrials.gov/study/NCT01075282>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01075282

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 810 participants.

## Technical summary

Registry record NCT01075282. Randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2012-05 (actual). Results posted on 2015-01-16.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 810 participants (enrolled count; ClinicalTrials.gov record NCT01075282, source copy `cardio:ctgov-nct01075282-2015-01-16`, retrieved 2026-10-26)
- Start date: 2010-02 (registry gives no type) (ClinicalTrials.gov record NCT01075282, source copy `cardio:ctgov-nct01075282-2015-01-16`, retrieved 2026-10-26)
- Primary completion: 2012-05 (actual) (ClinicalTrials.gov record NCT01075282, source copy `cardio:ctgov-nct01075282-2015-01-16`, retrieved 2026-10-26)
- Completion: 2012-11 (actual) (ClinicalTrials.gov record NCT01075282, source copy `cardio:ctgov-nct01075282-2015-01-16`, retrieved 2026-10-26)
- Results first posted: 2015-01-16 (ClinicalTrials.gov record NCT01075282, source copy `cardio:ctgov-nct01075282-2015-01-16`, retrieved 2026-10-26)
- Countries: Argentina; Australia; Belgium; Brazil; Canada; Croatia; Czechia; France; Greece; Hungary; India; Italy; Mexico; Poland; Romania; Slovakia; South Korea; Spain; Sweden; Taiwan (ClinicalTrials.gov record NCT01075282, source copy `cardio:ctgov-nct01075282-2015-01-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01075282-2015-01-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
- Acronym: AWARD-2
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): Insulin Glargine
- Intervention (Drug): LY2189265
- Intervention (Drug): Metformin
- Intervention (Drug): Glimepiride
- Lead sponsor: Eli Lilly and Company
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Eli Lilly and Company (`cardio:eli-lilly`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2) (`cardio:pubmed-26089386`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e7c3690e99c0d9a10097589a0394c7f1b690390117fc44691813c7dc6e257220
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
